A Study to Evaluate Potential Myocardial Injury Following Magnetic Resonance Imaging (MRI)


About this study

The purpose of this study is to prospectively determine if magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIED) results in myocardial injury as assessed by changes in high sensitivity cardiac troponin T (hs-cTnT) assay. This will be done by comparing pre-and-post MRI hs-cTnT levels in these patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients 18 years or older.
  • Patients who have cardiac implantable electronic devices (CIED), whether conditional or unconditional, regardless of the type of device; e.g., ICD, pacemakers, leadless pacemakers, who undergo magnetic resonance imaging (MRI) for any reason.

Exclusion Criteria: 

  • Patients under age 18.
  • Patients with myocardial infarction, coronary artery bypass grafting or any invasive cardiac procedure in the previous six weeks.
  • Pregnant patients.
  • Patients who cannot provide informed consent because of cognitive dysfunction.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ronstan Lobo, M.B., B.Ch., B.A.O.

Open for enrollment

Contact information:

Ronstan Lobo M.B., B.Ch., B.A.O.



More information


Publications are currently not available

Mayo Clinic Footer